Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06285097
Title A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
AdventHealth Celebration Infusion Center Celebration Florida 34747 United States Details
AdventHealth Celebration Celebration Florida 34747 United States Details
Florida Cancer Specialists Sarasota Drug Development Unit Sarasota Florida 34232 United States Details
Corewell Health (reference non-engagement letter) Grand Rapids Michigan 49503 United States Details
START Midwest Grand Rapids Michigan 49546 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
John Theurer Cancer Center at Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Sarah Cannon Research Institute - Pharmacy Nashville Tennessee 37203 United States Details
SCRI Oncology Partners Nashville Tennessee 37203 United States Details
Tristar Centennial Medical Center Nashville Tennessee 37203 United States Details
National Cancer Center Hospital East Kashiwa Chiba 277-8577 Japan Details
The Cancer Institute Hospital of JFCR Koto Tokyo 135-8550 Japan Details
Hospital Oncologico Dr. Isaac Gonzalez-Martinez Rio Piedras 00935 Puerto Rico Details
Pan American Center for Oncology Trials, LLC Rio Piedras 00935 Puerto Rico Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field